Study does not support probiotic use in certain critically ill patients

Study does not support probiotic use in certain critically ill patients

Critically ill patients who required mechanical ventilation and received the probiotic Lactobacillus rhamnosus GG were as likely to develop ventilator-associated pneumonia as those who received placebo, a randomized clinical trial showed.“Among critically ill patients, randomized trials suggest that probiotics reduce infection rates by 20% and may decrease the risk of ventilator-associated pneumonia by 25% to 30%,” Jennie Johnstone, MD, PhD, an associate professor of medical microbiology in the department of laboratory medicine and pathobiology at the University of Toronto, andRead More

Share on facebook
Share on twitter
Share on linkedin